Divalproex-na-structure (Divalproex Sod Dr 250mg Tab For Sun 1)
Divalproex Sodium
Product Images NDC 33261-641
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 33261-641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Divalproex-na-fig1 (Divalproex Sod Dr 250mg Tab For Sun 2)
Divalproex-na-fig2 (Divalproex Sod Dr 250mg Tab For Sun 3)
This text provides information on two studies conducted for the drug named Placebo DVPX. In both studies, participants were given divalproex sodium delayed-release tablets at different doses. In Study 1, the mean dose administered was 1087 mg/day. Study 2 administered doses of either 500 mg/day or 1000 mg/day. DVPX is explained as the abbreviation for the drug divalproex sodium delayed-release tablets.*
Divalproex-na-fig3 (Divalproex Sod Dr 250mg Tab For Sun 4)
This document appears to be a graph that shows the percentage reduction in CPS (central pain syndrome) rate in patients taking Divalproex sodium delayed-release tablets. The graph displays two bars, indicating that no improvement was seen in 50% of patients and worsening was observed in 2% of patients.*
Divalproex-na-fig4 (Divalproex Sod Dr 250mg Tab For Sun 5)
Image Label (Divalproex Sod Dr 250mg Tab For Sun 6)
This is a description of a medication named Divalproex Sod. DR. The manufacturer is Sun Pharmaceuticals Industries Ltd. in Mumbai, India. The medication comes in the form of delayed-release tablets, with each tablet containing 250 mg of valproic acid as its active ingredient. There are 30 tablets per bottle. The NDC codes for this medication are 83261-0841-50 and 33261-0841-30. The second NDC code corresponds to the generic form of the medication, which is used to treat a variety of conditions, including epilepsy and bipolar disorder.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
